Obalon Therapeutics, Inc. (OBLN)

Today's Latest Price: $6.02 USD

0.83 (15.99%)

Updated Jan 22 4:00pm

Add OBLN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 186 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

Obalon Therapeutics Inc (OBLN) Price Targets From Analysts

Use the tables below to see what analysts covering Obalon Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
1 $0.75 $0.75 $0.75 $5.19 -85.55%

OBLN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 0 0 1 0 0 NA

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The number of analysts covering the stock of OBLN is higher than nearly none of all US stocks.
  • Obalon Therapeutics Inc's variance in analysts' estimates is lower than just about 100% of all US stocks.
  • The average analyst price target of OBLN is greater than nearly none of Medical Equipment stocks.
  • Obalon Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than nearly none of Medical Equipment stocks.
  • Obalon Therapeutics Inc's percent of analysts bearish on the stock is lower than just about 100% of all US stocks.
  • The percentage of analysts bullish on the stock of OBLN is higher than nearly none of all US stocks.
  • OBLN has a less change in bullishness amongst analysts than just about 100% of all US stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to Obalon Therapeutics Inc are NTUS, AVGR and CMD.

Is OBLN a Buy, Hold or Sell? See the POWR Ratings now!



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5107 seconds.